Peptidylprolyl isomerase A pseudogene 33 (PPIAP33)

Peptidylprolyl isomerase A pseudogene 33 (PPIAP33) is a human pseudogene classified as a non-protein-coding genomic element similar in sequence to the parental gene Peptidylprolyl isomerase A (PPIA, Cyclophilin A). PPIA is an enzyme with diverse biological roles, including protein folding and immune response modulation; however, PPIAP33 does not encode a functional protein. Unlike the parental gene, there is no substantial evidence that PPIAP33 itself is involved in protein interactions, nor does it serve as a direct drug target. Emerging research suggests that some PPIA pseudogenes (notably PPIAP43, PPIAP22) may participate in the regulation of gene expression at the RNA level through ceRNA mechanisms, acting as RNA decoys for miRNAs in cancer and stress biology. These roles remain largely theoretical for PPIAP33 due to the lack of detailed functional studies. In summary, Peptidylprolyl isomerase A pseudogene 33 (PPIAP33) is a non-coding pseudogene, not a therapeutic target receptor, enzyme, transporter, or transcription factor. It has not been associated with direct drug interactions, known mechanisms of drug action, or established use as a biomarker or disease target. Its function is presumed to be regulatory at best, based on analogy to other related pseudogenes, but it is not an established molecule in molecular pharmacology or target discovery.